Alpine Global Management’s Starling Oncology Warrant STLNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02K Hold
25,024
– – ﹤0.01% 271
2026
Q1
$1.39K Hold
25,024
– – ﹤0.01% 222
2025
Q4
$4K Hold
25,024
– – ﹤0.01% 332
2025
Q3
$3K Hold
25,024
– – ﹤0.01% 206
2025
Q2
$1.28K Hold
25,024
– – ﹤0.01% 162
2025
Q1
$678 Hold
25,024
– – ﹤0.01% 130
2024
Q4
$175 Hold
25,024
– – ﹤0.01% 172
2024
Q3
$500 Hold
25,024
– – ﹤0.01% 160
2024
Q2
$508 Hold
25,024
– – ﹤0.01% 462
2024
Q1
$5K Hold
25,024
– – ﹤0.01% 193
2023
Q4
$3.25K Hold
25,024
– – ﹤0.01% 186
2023
Q3
$2.13K Hold
25,024
– – ﹤0.01% 154
2023
Q2
$1.13K Hold
25,024
– – ﹤0.01% 199
2023
Q1
$1.52K Hold
25,024
– – ﹤0.01% 111
2022
Q4
$3K Hold
25,024
– – ﹤0.01% 436
2022
Q3
$13K Hold
25,024
– – ﹤0.01% 176
2022
Q2
$13K Hold
25,024
– – ﹤0.01% 228
2022
Q1
$29K Hold
25,024
– – 0.01% 340
2021
Q4
$17K Sell
25,024
-1
-0% -$1 ﹤0.01% 728
2021
Q3
$32K Hold
25,025
– – 0.01% 285
2021
Q2
$43K Hold
25,025
– – 0.01% 286
2021
Q1
$30K Hold
25,025
– – ﹤0.01% 297
2020
Q4
$49K Hold
25,025
– – 0.01% 195
2020
Q3
$43K Buy
+25,025
New +$41.1K 0.01% 211

Other funds holding STLNW

Alpine Global Management's STLNW Position: Q2 2026 in Review

Alpine Global Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 25,024 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Alpine Global Management first reported a position in STLNW in Q3 2020 and has held it in 24 quarters since. The position peaked at $49K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

  • Alpine Global Management held 25,024 shares of Starling Oncology Warrant worth $1.02K as of Q2 2026.
  • Alpine Global Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
  • Starling Oncology Warrant made up ﹤0.01% of Alpine Global Management's portfolio in Q2 2026, its #271 holding.
  • Alpine Global Management first reported a position in Starling Oncology Warrant in Q3 2020 and has held it in 24 quarters since.
  • Alpine Global Management's Starling Oncology Warrant position peaked at $49K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.